The effectiveness of complex therapy for heart failure of various etiologies in comorbid patients
- Authors: Kryukov E.V1, Tsygvintsev A.A2, Lishchuk A.N2, Shakhnovich P.G3
-
Affiliations:
- The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
- the 3rd A.A.Vishnevsky Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- Issue: Vol 342, No 5 (2021)
- Pages: 33-38
- Section: Articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/82579
- DOI: https://doi.org/10.52424/00269050_2021_342_5_33
- ID: 82579
Cite item
Open Access
Access granted
Abstract
The management of patients with chronic heart failure is one of the most pressing problems of modern cardiology. There are currently objective difficulties in diagnostics, conservative treatment, and the provision of high - tech medical care, which worsen the prognosis and cause high hospital mortality throughout the world. In this regard, the medical community has high hopes for introducing neprilysin inhibitors into clinical practice. However, the effects of long - term administration of sacubitril/valsartan in age - related comorbid patients have not been sufficiently studied. This paper presents the results of long - term clinical observation of patients with chronic heart failure of various etiologies.
Full Text
About the authors
E. V Kryukov
The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian FederationSt. Petersburg, Russia
A. A Tsygvintsev
the 3rd A.A.Vishnevsky Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: tsygvintsev1985@gmail.com
Krasnoznamensk, Moscow Region, Russia
A. N Lishchuk
the 3rd A.A.Vishnevsky Central Military Clinical Hospital of the Ministry of Defense of the Russian FederationKrasnogorsk, Moscow Region, Russia
P. G Shakhnovich
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: p_shakhnovich@mail.ru
Moscow, Russia
References
- Европейское руководство по неотложной кардиологии / Под ред. Тубаро М., Вранкс П. - М.: ГЭОТАР-Медиа, 2017. - 960 с.
- Зырянов С.К., Чеберда А.Е., Белоусов Д.Ю. Фармакоэкономический анализ лекарственной терапии хронической сердечной недостаточности у больных с коморбидной патологией // Рациональная Фармакотерапия в Кардиологии. 2018. - Т. 14, № 2. - С. 167-175.
- Клинические рекомендации ОССН - РКО - РНМОТ. Сердечная недостаточность: Хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение // Кардиология. - 2018. - Т. 58, № 6. - С. 8-158.
- Руководство по кардиологии в четырех томах. Том 4: Заболевания сердечно-сосудистой системы / Под ред. Е.И.Чазова - М.: Практика, 2014. - 976 с.
- Терещенко С.Н., Жиров И.В. Хроническая сердечная недостаточность: новые вызовы и новые перспективы // Тер. арх. - 2017. - Т. 89, № 9. - С. 4-9.
- Цыгвинцев А.А., Лищук А.Н., Сторожилов В.А., Иванов Д.В. Обратимая дилятация полостей сердца как маркер новых возможностей в терапии воспалительной и дилятационной кардиомиопатии // Вестн. новых медицинских технологий. - 2019 - Т. 26, № 4 - С. 3-5.
- Armstrong P., Pieske B., Anstrom K. et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction // N. Engl. J. Med. - 2020. - N 382. - P. 1883-1893.
- Gonzalez A., Schelbert E., Diez J. et al. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives // J. Am. Coll. Cardiol. - 2018. - Vol. 71, N 15. - P. 1696-1706.
- Jhund P., Claggett B., Packer M. et al. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial // Eur. J. Heart Fail. - 2014. - Vol. 16, N 6. - P. 671-677.
- Simpson J., Castagno D., Doughty R. et al. Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results From the MAGGIC Meta-Analysis // Eur. J. Heart Fail. - 2015. - Vol. 17, N 11. - P. 1182-1191.
- Su X., Zhang L., Lv J., Wang J. et al. Effect of statins on kidney disease outcomes: a systematic review and meta-analysis // Am. J. Kidn. Dis. - 2016. - Vol. 67, N 6. - P. 881-892.
- Vitale G., Romano G., Di Franco A. et. al. Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction // J. Clin. Med. - 2019. - Vol. 8, N 2. - P. 262.
- Zinman B., Wanner C., Lachin J. et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes // N. Engl. J. Med. - 2015. - Vol. 373, N 22. - P. 2117-2128.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).